Expression profile of class I histone deacetylases in human cancer tissues. - Wikidata - awgldk - TriplyDB

Expression profile of class I histone deacetylases in human cancer tissues.

Expression profile of class I histone deacetylases in human cancer tissues.

http://www.wikidata.org/entity/Q34677171

about

Role of histone deacetylases in pancreas: Implications for pathogenesis and therapy Epigenetics of lung cancer Epigenetic treatment of pancreatic cancer: is there a therapeutic perspective on the horizon?The Triple-Code Model for Pancreatic Cancer: Cross Talk Among Genetics, Epigenetics, and Nuclear Structure Anticancer activity of MPT0E028, a novel potent histone deacetylase inhibitor, in human colorectal cancer HCT116 cells in vitro and in vivo Histone deacetylase 1 is required for exocrine pancreatic epithelial proliferation in development and cancer.HDAC3 as a molecular chaperone for shuttling phosphorylated TR2 to PML: a novel deacetylase activity-independent function of HDAC3.Plant flavone apigenin inhibits HDAC and remodels chromatin to induce growth arrest and apoptosis in human prostate cancer cells: in vitro and in vivo study.Histone deacetylase inhibitors: a chemical genetics approach to understanding cellular functions.Combination of azacitidine and trichostatin A decreased the tumorigenic potential of lung cancer cells.The clinical development of histone deacetylase inhibitors as targeted anticancer drugs.Interplay between epigenetics and metabolism in oncogenesis: mechanisms and therapeutic approaches Modulation of Activity Profiles for Largazole-Based HDAC Inhibitors through Alteration of Prodrug Properties Epigenetic control of gene function in schistosomes: a source of therapeutic targets?Long non-coding RNAs differentially expressed between normal versus primary breast tumor tissues disclose converse changes to breast cancer-related protein-coding genes.Effects of valproic acid on the cell cycle and apoptosis through acetylation of histone and tubulin in a scirrhous gastric cancer cell line Histone Deacetylase Inhibitors: Advancing Therapeutic Strategies in Hematological and Solid Malignancies.Histone deacetylase inhibitors in the treatment of hematological malignancies and solid tumors.Nuclear receptor corepressor complexes in cancer: mechanism, function and regulation Crucial function of histone deacetylase 1 for differentiation of teratomas in mice and humans Transcription factor-microRNA-target gene networks associated with ovarian cancer survival and recurrence.HDAC up-regulation in early colon field carcinogenesis is involved in cell tumorigenicity through regulation of chromatin structure.MicroRNA Regulating Glutathione S-Transferase P1 in Prostate Cancer.Expression of histone deacetylases in lymphoma: implication for the development of selective inhibitors.The inactive X chromosome is epigenetically unstable and transcriptionally labile in breast cancer Potential non-oncological applications of histone deacetylase inhibitors.Molecular Mechanism of the Cell Death Induced by the Histone Deacetylase Pan Inhibitor LBH589 (Panobinostat) in Wilms Tumor Cells.An atlas of histone deacetylase expression in breast cancer: fluorescence methodology for comparative semi-quantitative analysis.Targeting Histone Deacetylases in Diseases: Where Are We?Oxidative stress induced lung cancer and COPD: opportunities for epigenetic therapy.Epigenetics modifications and therapeutic prospects in human thyroid cancer.Histone deacetylase inhibitors: clinical implications for hematological malignancies.Vitamin D resistance and colon cancer prevention.Anticancer activity of MPT0G157, a derivative of indolylbenzenesulfonamide, inhibits tumor growth and angiogenesis Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host Epigenetically downregulated Semaphorin 3E contributes to gastric cancer Vorinostat, an HDAC inhibitor attenuates epidermoid squamous cell carcinoma growth by dampening mTOR signaling pathway in a human xenograft murine model.Histone deacetylase inhibitor-induced cell death in bladder cancer is associated with chromatin modification and modifying protein expression: A proteomic approach.Discovery and mechanism of natural products as modulators of histone acetylation.Influence of a novel histone deacetylase inhibitor panobinostat (LBH589) on the growth of ovarian cancer.

P2860

Q26774080-A9748B68-B967-41DE-B5B4-0A5EDD02FEDB Q26996766-FE8100EF-BB0D-4B32-9063-F9D9F033FA1C Q28076548-8EABE42C-A8FB-4408-90C4-79CE73775C81 Q28084785-C909DC50-DDCE-4F36-8E46-9340AB23ECBA Q28482468-4E6D0533-0CBD-49A6-B335-8070E790DAB8 Q30499964-3569F0C4-50D1-4CC3-A22F-48FD68FAAE04 Q33407184-8F8E7686-B11A-4106-9F8E-724E8B0958AB Q33606387-47561D46-B00A-49FF-BE8A-A03E1A18E1B9 Q33705588-F44475EC-D3F7-4848-9DFF-0E64E7C0E322 Q33813245-62DDE4B0-D9D0-4F77-8DBD-50667A231F0D Q33829390-57A1E7A5-2762-4F80-BD42-D71CDBB77246 Q33835913-9058FB61-55BD-49F1-BA1C-62B38DA91CF4 Q34063722-B301C1EB-63B9-4A9D-8CD8-435F9EFE34DB Q34159188-550D6F35-0DA4-4162-BB87-C74BC8151E13 Q34267035-29B18539-0864-4062-8FB3-B4F369304A2B Q34366588-AD6BF0B7-3AA0-4216-8CBB-0E7B725DAB07 Q34399444-81CB781E-AF37-4936-AEB8-288DCD5E69D2 Q34416994-CF96F9D5-E414-4DE3-9848-18A776B7CBB6 Q34448240-9288A132-4677-4830-87D8-5F17A7BB150A Q34488391-4E88D207-F942-4E55-9827-90528DF5ABF5 Q34648126-C178BBB3-BE52-402E-AC55-548890528AE2 Q34749665-85AD3949-50FB-4870-849E-507D7C0247A6 Q35163033-35147A2B-DE6A-4F82-9CEF-5C426256876D Q35235267-26BE33B6-2870-4493-9864-17C069A2E690 Q35238263-FD4B4113-1E57-407F-AA63-2FE52E07DD0F Q35485587-FA522963-B309-421E-BE3C-8237C7A347D6 Q35691776-7380C1EE-8932-491A-B194-5F4B17A65E6B Q35747470-8C2B2F32-5B44-49C6-9085-13FECDFE7FD1 Q35821728-6A427E66-8F45-4DA6-A353-706D1AF89CDD Q35841917-3FCE238D-7756-4CEC-B671-9DF3DD9A0D05 Q35971504-A0E7C1D5-D6DF-4949-AD51-ACEB9BE743E4 Q36001847-9D3437A9-5CE0-4B1C-86EC-46099607E517 Q36061123-A5BD6C04-CF8B-4819-8CFD-C1BC009C383D Q36210950-C3CCA2B6-E9BF-4226-A0B2-89702EC246ED Q36257990-622D4C02-BECE-407C-BF6D-82CFC56C4BD8 Q36299715-3088F79E-733C-4864-88B1-0F056A5E1BE1 Q36501207-08ADBD94-B100-478A-9DBC-E41531CA1784 Q36893027-807C8EAD-2529-42E3-A8DE-2F9E0F71089A Q37242496-B1C1CEBD-5A4F-4BD8-A963-FF3D808A8458 Q37260402-C6FA5FAE-B2F4-4D4A-8971-577D23EB1539

P2860

Expression profile of class I histone deacetylases in human cancer tissues.

http://www.wikidata.org/entity/Q34677171

description

2007 nî lūn-bûn

@nan

2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Expression profile of class I histone deacetylases in human cancer tissues.

@ast

Expression profile of class I histone deacetylases in human cancer tissues.

@en

Expression profile of class I histone deacetylases in human cancer tissues.

@nl

type

label

Expression profile of class I histone deacetylases in human cancer tissues.

@ast

Expression profile of class I histone deacetylases in human cancer tissues.

@en

Expression profile of class I histone deacetylases in human cancer tissues.

@nl

prefLabel

Expression profile of class I histone deacetylases in human cancer tissues.

@ast

Expression profile of class I histone deacetylases in human cancer tissues.

@en

Expression profile of class I histone deacetylases in human cancer tissues.

@nl

P1433

Q34677171-4B198F85-8746-4D37-BEAE-FE6B7A7D92A3

P1476

Q34677171-D5651BED-E96E-4F50-B8B4-CDFA60BF7333

P2093

Q34677171-2691DF85-FC67-40DC-968D-178E89576DAA

Q34677171-5D96076D-43F3-4A80-9FAB-646D59FF3BE2

Q34677171-60888632-F828-4507-8528-5306F0C0901E

Q34677171-71C6A0BB-10D4-4614-AE09-BEEE64448A1F

Q34677171-80040829-5D6A-4BC4-B429-30E0B290FE3A

Q34677171-95A2DA3C-A5F8-4939-B940-BA879CB7B493

Q34677171-9D474186-FFCD-4D8B-99A6-398782083DC5

Q34677171-A25B2346-FBCD-4D9C-B1B2-EE25A3F5FCD9

Q34677171-A4A34F84-81D3-410A-AA36-4757819EAAD2

Q34677171-B2A5FDA5-7493-4B64-AA00-45DD1C058099

P304

Q34677171-C15D8AC8-5EFC-466C-B3F5-7C21BE12B335

P31

Q34677171-F07A2FD6-3FBC-4BDA-8385-0E3224D4A7A6

P433

Q34677171-55FBF506-C0E6-42C8-BF9F-ACA5FE738319

P478

Q34677171-B0957FF3-BC84-4945-9619-00188F426BDF

P577

Q34677171-818C6BDA-6ED7-43E9-9366-8B01BD69DEA4

P698

Q34677171-CA4B4A53-C18E-444E-86C3-7BF959BBCDC5

P1433

Oncology Reports

P1476

Expression profile of class I histone deacetylases in human cancer tissues

@en

P2093

Fumihito Hosoi

http://www.w3.org/2001/XMLSchema#string

Masamune Nakagawa

http://www.w3.org/2001/XMLSchema#string

Masao Tanaka

http://www.w3.org/2001/XMLSchema#string

Masazumi Tsuneyoshi

http://www.w3.org/2001/XMLSchema#string

Mayumi Ono

http://www.w3.org/2001/XMLSchema#string

Michihiko Kuwano

http://www.w3.org/2001/XMLSchema#string

Shin-Ichi Aishima

http://www.w3.org/2001/XMLSchema#string

Takashi Eguchi

http://www.w3.org/2001/XMLSchema#string

Takashi Yao

http://www.w3.org/2001/XMLSchema#string

Yoshinao Oda

http://www.w3.org/2001/XMLSchema#string

P304

769-774

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

2007-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17786334

http://www.w3.org/2001/XMLSchema#string